WebFeb 15, 2024 · KKR-controlled Gamma, is expected to, following completion of the transaction, become the largest shareholder in Biotage, with approximately 17.0% of shares outstanding. Tomas Blomquist, CEO and President at Biotage, said: “We are proud to welcome the Astrea Bioseparations team to Biotage. The acquisition represents an … WebApr 8, 2024 · Tomas Blomquist, CEO/President. Read the annual report and previous reports here. Written by Biotage. Learn From Future Blog Posts. About Biotage. Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in Drug Discovery and Development, Analytical …
Tomas Blomquist - CEO & President - Biotage AB, …
WebDec 6, 2024 · Torben Jörgensen, CEO of Biotage, comments: "The acquisition of Horizon is in line with our strategy to grow our separation business through expansion into new application areas. This Transaction enables Horizon’s existing products to reach a larger global market through Biotage’s direct sales channels, at the same time as Biotage’s ... WebMay 24, 2024 · UPPSALA, Sweden, May 24, 2024 /PRNewswire/ -- Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – Biotage has appointed Tomas Blomquist as the … flowers to grow outside
Biotage Acquires PhyNexus, Inc. and Strengthens its Position in Lab ...
WebFeb 15, 2024 · Tomas Blomquist, CEO and President at Biotage, said: “We are proud to welcome the Astrea Bioseparations team to Biotage. The acquisition represents an excellent strategic fit for Biotage, and it will add to us a high-growth company with a talented global team with decades of experience. It also scales our Biologics and Advanced … WebFeb 15, 2024 · KKR-controlled Gamma, is expected to, following completion of the transaction, become the largest shareholder in Biotage, with approximately 17.0% of shares outstanding. Tomas Blomquist, CEO and President at Biotage, said: "We are proud to welcome the Astrea Bioseparations team to Biotage. The acquisition represents an … WebFeb 11, 2024 · Interim Report January-June 2024. July 19, 2024. Interim Report January-September 2024. November 2, 2024. Year-end Report 2024. February 15, 2024. The interim report for Biotage AB (publ) has been issued by the Company's President and CEO Tomas Blomquist after authorization by the Board of Directors. greenbrier baptist church arlington va